Development of cell-based DDS to overcome biological barriers for treating brain diseases

January 25, 2026Drug Delivery SystemOpen Access

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to explore the development of cell-based drug delivery systems (DDS) that can effectively navigate biological barriers for treating brain diseases.
Review of recent trends in cell-based DDS for central nervous system disorders.
Utilization of circulating cells, particularly neutrophils, for DDS development.
Focus on cell engineering techniques aimed at cancer immunotherapy applications.
Enhancements in drug delivery efficacy noted through the use of inflammation-responsive cells.
Positive implications for using neutrophils in drug delivery and cancer treatment.
Advancements in cell engineering systems to facilitate targeted immunotherapy strategies.

Demonstrates effectiveness of cell-based drug delivery systems in overcoming biological barriers, suggesting new treatment pathways.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Tatsuya Fukuta (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share